Sumitomo Mitsui Trust Group’s Iovance Biotherapeutics IOVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,490,600	Closed	-$17.5M	–	1152
2023 Q2	$17.5M	Sell	2,490,600 -82,491	-3%	-$590K	0.01%	732
2023 Q1	$15.7M	Sell	2,573,091 -14,527	-0.6%	-$100K	0.01%	745
2022 Q4	$16.5M	Sell	2,587,618 -111,795	-4%	-$873K	0.01%	741
2022 Q3	$25.9M	Sell	2,699,413 -100,229	-4%	-$1.16M	0.02%	664
2022 Q2	$30.9M	Buy	2,799,642 +421,306	+18%	+$5.52M	0.02%	642
2022 Q1	$39.6M	Sell	2,378,336 -2,586,760	-52%	-$40M	0.03%	599
2021 Q4	$94.8M	Sell	4,965,096 -1,415,707	-22%	-$31.2M	0.06%	356
2021 Q3	$157M	Sell	6,380,803 -1,356,815	-18%	-$32M	0.1%	225
2021 Q2	$201M	Buy	7,737,618 +2,434,885	+46%	+$63.3M	0.12%	191
2021 Q1	$168M	Buy	5,302,733 +878,823	+20%	+$36.4M	0.1%	217
2020 Q4	$205M	Buy	4,423,910 +904,165	+26%	+$35.9M	0.13%	176
2020 Q3	$116M	Buy	3,519,745 +759,199	+28%	+$23.3M	0.08%	271
2020 Q2	$75.8M	Buy	2,760,546 +1,640,024	+146%	+$53.9M	0.05%	378
2020 Q1	$33.5M	Sell	1,120,522 -205,987	-16%	-$5.46M	0.03%	546
2019 Q4	$36.7M	Sell	1,326,509 -29,793	-2%	-$678K	0.03%	566
2019 Q3	$24.7M	Buy	1,356,302 +92,206	+7%	+$2.04M	0.02%	619
2019 Q2	$31M	Buy	1,264,096 +809,398	+178%	+$12.2M	0.03%	578
2019 Q1	$4.32M	Buy	+454,698	New	+$4.42M	﹤0.01%	732